This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor: I am afraid that your reviewer read my recent article (Silverman, W. A.: The Status of Two-Year-Old Children Who Had Received Sulfisoxazole in the Neonatal Period After Premature Birth, J. Pediat. 54:741, 1959) with a somewhat jaundiced eye. He wrote, "The previous paper reported a significantly higher incidence of hyperbilirubinemia and kernicterus in those receiving the combination of penicillin and sulfisoxazole" (Traggis, D. G.: Abstract, A.M.A.J. Dis. Child. 99:394, 1960). As a matter of fact we reported (Silverman, W. A.; Andersen, D. H.; Blanc, W. A., and Crozier, D. N.: A Difference in Mortality Rate and Incidence of Kernicterus Among Premature Infants Allotted to Two Prophylactic Antibacterial Regimens, Pediatrics 18:614, 1956) that the incidence of hyperbilirubinemia was not higher in the infants who received these drugs.
Though I write primarily to reveal this error, I cannot resist pointing out how often this kind of mistake occurs. It
SILVERMAN WA. SULFISOXAZOLE IN THE NEONATAL PERIOD AFTER PREMATURE BIRTH. AMA Am J Dis Child. 1960;100(1):133. doi:10.1001/archpedi.1960.04020040135023
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.